Awards Clustered Just Under the Small Value Procurement Ceiling
3+ awards from one office to one supplier within 30 days, each 85–100% of the SVP ceiling, combined above it.
This is a statistical anomaly or indicator worth examining — not proof of wrongdoing, fraud, or corruption against any person.
Indicator: 5 awards from JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL to GLOBO ASIATICO ENTERPRISES,INC between 2024-07-04 and 2024-07-27 were each between 85% and 100% of the ₱1.00M Small Value Procurement ceiling then in force (2016 Revised IRR of RA 9184, Annex H), totalling ₱4.99M. Worth checking whether they were separate requirements. The hospital may have had separate urgent requests for different patients or treatment cycles, requiring multiple purchases within a short time.
Only contractors and government agencies named in public procurement records are shown. Private individuals are not named.
Named in this indicator? Respond or report an error · Corrections policy
Project completion
Schedule fields from DPWH transparency portal records and the Sumbong sa Pangulo flood-control list — not inferred beyond those columns.
Completion schedule is shown for project and contractor flags only.
Rule Definition
SVP ceiling in force on the award date: ₱500,000 (2009 IRR of RA 9184, Annex H), ₱1,000,000 (2016 Revised IRR, Annex H), ₱2,000,000 (IRR of RA 12009, Sec. 34). Splitting contracts to avoid competitive bidding is prohibited under the IRR.
Triggering Data & citations
5 awards from JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL to GLOBO ASIATICO ENTERPRISES,INC between 2024-07-04 and 2024-07-27, each between 85% and 100% of the ₱1,000,000 Small Value Procurement ceiling, totalling ₱4,991,858.
{
"awards": [
{
"url": "/agency-awards/0c454b96-e8f4-4286-8d8f-7a177e632ca0",
"title": "Trastuzumab (CSPMAP) 600mg/5ml vial",
"office": "JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL",
"awardId": "0c454b96-e8f4-4286-8d8f-7a177e632ca0",
"awardee": "GLOBO ASIATICO ENTERPRISES,INC",
"amountPhp": 998214.47,
"awardDate": "2024-07-04",
"referenceId": "309-2024BAC",
"businessCategory": "Drugs and Medicines"
},
{
"url": "/agency-awards/2a43d486-4656-44a4-835c-175170d1f56f",
"title": "Epoetin Beta (Recombinant Erythropoetin) 5,000 IU/",
"office": "JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL",
"awardId": "2a43d486-4656-44a4-835c-175170d1f56f",
"awardee": "GLOBO ASIATICO ENTERPRISES,INC",
"amountPhp": 999000,
"awardDate": "2024-07-10",
"referenceId": "317-2024BAC",
"businessCategory": "Drugs and Medicines"
},
{
"url": "/agency-awards/b0748b8a-2ec3-4a45-8f06-2bcaf7a2f358",
"title": "Trastuzumab (CSPMAP) 600mg/5ml vial",
"office": "JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL",
"awardId": "b0748b8a-2ec3-4a45-8f06-2bcaf7a2f358",
"awardee": "GLOBO ASIATICO ENTERPRISES,INC",
"amountPhp": 998214.47,
"awardDate": "2024-07-19",
"referenceId": "325-2024BAC",
"businessCategory": "Drugs and Medicines"
},
{
"url": "/agency-awards/1dd93fe0-0e2a-42ed-8e53-8cf64fa30350",
"title": "Trastuzumab (CSPMAP) 600mg/5ml vial",
"office": "JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL",
"awardId": "1dd93fe0-0e2a-42ed-8e53-8cf64fa30350",
"awardee": "GLOBO ASIATICO ENTERPRISES,INC",
"amountPhp": 998214.47,
"awardDate": "2024-07-19",
"referenceId": "325-2024",
"businessCategory": "Drugs and Medicines"
},
{
"url": "/agency-awards/29626a28-c17a-4a92-aaf3-23ca9016e9a5",
"title": "Trastuzumab (CSPMAP) 600mg/5ml vial",
"office": "JOSE B. LINGAD MEMORIAL GENERAL HOSPITAL",
"awardId": "29626a28-c17a-4a92-aaf3-23ca9016e9a5",
"awardee": "GLOBO ASIATICO ENTERPRISES,INC",
"amountPhp": 998214.47,
"awardDate": "2024-07-27",
"referenceId": "134-2024",
"businessCategory": "Drugs and Medicines"
}
],
"totalPhp": 4991857.88,
"ceilingPhp": 1000000,
"ceilingUrl": "https://www.gppb.gov.ph/wp-content/uploads/2024/07/Updated-2016-Revised-IRR-of-RA-No.-9184-as-of-19-July-2024.pdf",
"windowDays": 30,
"ceilingCitation": "2016 Revised IRR of RA 9184, Annex H — SVP ceiling ₱1,000,000 for NGAs"
}Source documents
Possible Innocent Explanations
- Separate requisitions from different schools/units or recurring needs can fall near the ceiling legitimately; splitting is prohibited only when done to avoid competitive bidding.